- GlobeNewswire•16 days ago
SAN DIEGO, Feb. 07, 2017-- Conatus Pharmaceuticals Inc. today announced the appointment of William R. LaRue as an additional independent member to the Conatus Board of Directors. LaRue also will serve ...
- GlobeNewswire•17 days ago
SAN DIEGO, Feb. 06, 2017-- Conatus Pharmaceuticals Inc. today announced its scheduled presentation to provide an overview of the company’ s programs and outlook at the Biotechnology Industry Organization ...
- GlobeNewswire•20 days agoConatus Pharmaceuticals Promotes Daniel L. Ripley to Senior Vice President, Business Development, Program and Alliance Management
SAN DIEGO, Feb. 02, 2017-- Conatus Pharmaceuticals Inc. announced today the promotion of Daniel L. Ripley to Senior Vice President, Business Development, Program and Alliance Management, effective immediately. ...
CNAT : Summary for Conatus Pharmaceuticals Inc. - Yahoo Finance
Conatus Pharmaceuticals Inc. (CNAT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.00 x 1000|
|Ask||5.28 x 300|
|Day's Range||4.71 - 5.09|
|52 Week Range||1.45 - 6.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-3.82|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|